Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals ALNY
$ 249.98 -1.2%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Alnylam Pharmaceuticals Financial Statements 2011-2024 | ALNY

Annual Financial Statements Alnylam Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

18.6 B 23.7 B 18.7 B 17 B 12.6 B 8.22 B 11.9 B 3.16 B 5.79 B 6.97 B 5.29 B 1.2 B 473 M

Shares

125 M 122 M 118 M 115 M 109 M 101 M 90.6 M 85.6 M 84 M 74.3 M 61.6 M 50.3 M 42.4 M

Historical Prices

149 195 158 148 118 85 120 51.6 58.6 102 81.2 23.7 13.3

Net Income

-440 M -1.13 B -853 M -858 M -886 M -761 M -491 M -410 M -290 M -360 M -89.2 M -106 M -57.6 M

Revenue

1.83 B 1.04 B 844 M 493 M 220 M 74.9 M 89.9 M 47.2 M 41.1 M 50.6 M 47.2 M 66.7 M 82.8 M

Cost of Revenue

268 M 140 M 115 M 74.2 M 25.1 M 1.8 M - - - - - - -

Gross Profit

- - - - 195 M 73.1 M - - - - - - 82.8 M

Operating Income

-282 M -785 M -709 M -828 M -939 M -815 M -500 M -425 M -296 M -405 M -92.9 M -129 M -54.8 M

Interest Expense

121 M 156 M 143 M 84.5 M - - -3.02 M 6.17 M 76 K 1.82 M -47 K 331 K -531 K

EBITDA

-228 M -741 M -661 M -794 M -885 M -808 M -487 M -409 M -277 M -172 M -82.7 M -54.5 M -49.7 M

Operating Expenses

- - - - 1.13 B 888 M 590 M 472 M 337 M 235 M 140 M 130 M 138 M

General and Administrative Expenses

796 M 771 M 621 M 588 M 479 M 382 M 199 M 89.4 M 60.6 M 44.5 M 27.2 M 43.7 M 38.3 M

All numbers in USD currency

Quarterly Income Statement Alnylam Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

129 M 127 M 126 M 126 M 125 M 125 M 124 M 124 M 122 M 121 M 120 M 120 M 119 M 118 M 117 M 116 M 116 M 115 M 113 M 112 M 109 M 109 M 105 M 101 M 101 M 101 M 100 M 96.1 M 91.8 M 88.1 M 86 M 85.8 M 85.7 M 85.5 M 85.3 M 84.9 M 84.6 M 84.4 M 82.1 M 77 M 76.4 M 75.8 M 67.8 M 62.9 M 62.4 M 61.7 M 59.2 M 51.8 M 51.5 M 51.3 M 46.2 M 42.7 M 42.7 M 42.4 M 42.3 M

Net Income

-112 M -16.9 M -65.9 M - 148 M -276 M -174 M - -406 M -277 M -240 M - -205 M -190 M -200 M -244 M -253 M -179 M -182 M -276 M -209 M -219 M -182 M -211 M -245 M -164 M -141 M -142 M -123 M -118 M -107 M -113 M -104 M -90.1 M -103 M -90.7 M -76.8 M -71.8 M -50.8 M -21.4 M -44 M -44.1 M -251 M -32.4 M -29.7 M -18.2 M -9.01 M -62.2 M -19.5 M -13 M -11.4 M -14.3 M -13.2 M -13.8 M -16.3 M

Revenue

501 M 660 M 494 M - 751 M 319 M 319 M - 264 M 225 M 213 M - 188 M 221 M 178 M 164 M 126 M 104 M 99.5 M 71.7 M 70.1 M 44.7 M 33.3 M 21 M 2.07 M 29.9 M 21.9 M 37.9 M 17.1 M 15.9 M 19 M - - - - - - - - - - - - - - - - - -1.61 M -1.14 M -889 K - -467 K -1.01 M 20.9 M

Cost of Revenue

82 M 67.3 M 54.6 M - 79.5 M 75.3 M 41.4 M - 36.5 M 34 M 23.5 M - 28.1 M 30.3 M 23 M - 20.8 M 18.3 M 13.3 M - 5.21 M 4.33 M 3.35 M - 137 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-76.9 M 48.6 M -43.4 M - 214 M -230 M -150 M - -258 M -192 M -147 M - -182 M -146 M -186 M - -225 M -199 M -210 M - -216 M -236 M -189 M - -255 M -192 M -147 M - -126 M -120 M -107 M - -107 M -92.4 M -110 M - -78.3 M -72.9 M -52.2 M - -45.2 M -45 M -269 M - -32.2 M -21.3 M -9.8 M - -18.1 M -12.1 M -10.9 M - -12.4 M -13.1 M -15.7 M

Interest Expense

-29.5 M -55.7 M 35.3 M - -57.7 M -35.4 M 29 M - 41.1 M 42.6 M 42.4 M - 40.3 M 33.4 M 32.5 M - 28.7 M 27.2 M - - - - 43 K - 2.92 M 2.21 M 335 K - -433 K -523 K -2.91 M - 401 K 229 K 5.24 M - -72 K -27 K - - 524 K -77 K -82 K - -12 K -11 K 5 K - -3 K -21 K 191 K - -597 K -16 K 81 K

EBITDA

- - -29.9 M - - - -136 M - -228 M -192 M -137 M - -145 M -146 M -174 M - -201 M -183 M -203 M - -205 M -229 M -185 M - -249 M -187 M -144 M - -116 M -114 M -104 M - -94.6 M -83.8 M -105 M - -64.3 M -64.2 M -48.5 M - -36.6 M -39.5 M -266 M - -24.6 M -16.5 M -7.68 M - -11.1 M -7.34 M -8.77 M - -8.55 M -10.5 M -14.3 M

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - 222 M 169 M 185 M 143 M 136 M 125 M 133 M 120 M 101 M 117 M 100 M 84.7 M 81.6 M 70.8 M 69.7 M 56.2 M 52.3 M 277 M 40.4 M 41.2 M 30 M 28.4 M 96.8 M 34.9 M 33 M 31.5 M 34 M 33.2 M 33.7 M 36.6 M

General and Administrative Expenses

221 M 248 M 211 M - 199 M 215 M 184 M - 236 M 170 M 154 M - 142 M 145 M 147 M - 167 M 128 M 127 M - 120 M 113 M 89.6 M - 117 M 84.7 M 72.4 M - 47.6 M 45.8 M 38.5 M - 22.4 M 18 M 21.1 M - 16 M 14.6 M 12.7 M - 9.9 M 11.5 M 8.92 M - 6.77 M 5.78 M 6.27 M - 12.8 M 11.2 M 10.4 M - 8.96 M 8.43 M 10.2 M

All numbers in USD currency